|
Yale SPORE in Skin Cancer
|
3P50CA121974-05S1
|
$500,000
|
$500,000
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S1
|
$35,000
|
$350
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S2
|
$5,000
|
$50
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-33
|
$1,795,225
|
$17,952
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Virus-Like Particle Based Antigen Display as Multi-component Anticancer Vaccines
|
1R01CA149451-01A1
|
$501,816
|
$250,908
|
HUANG, XUEFEI
|
MICHIGAN STATE UNIVERSITY
|
|
Virginia Mason Community Clinical Oncology Program
|
2U10CA035192-27A1
|
$569,700
|
$5,697
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$48,591
|
$2,429
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
VEGFs in tumor lymphatic metastasis
|
4R01CA142262-03
|
$453,456
|
$317,419
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-21S1
|
$50,000
|
$500
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-21
|
$490,679
|
$4,907
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
5P50CA128323-04
|
$1,200,072
|
$36,002
|
GORE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Validation of Grm1 as a Therapeutic Target in Melanoma
|
5R01CA124975-05
|
$286,624
|
$286,624
|
GOYDOS, JAMES
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Validation of Genomic Targets in Melanoma
|
2R01CA114337-07A1
|
$370,543
|
$370,543
|
KASHANI-SABET, MOHAMMED
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Vaccines to promote Tc-1-based targeting of tumor stroma
|
5R01CA140375-02
|
$296,440
|
$148,220
|
Storkus, Walter
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Vaccination with IL-15 DC to Generate Melanoma-specific Protective Memory T Cells
|
5R01CA140602-02
|
$389,282
|
$389,282
|
PALUCKA, ANNA KAROLINA
|
BAYLOR RESEARCH INSTITUTE
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S1
|
$74,970
|
$1,499
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S2
|
$139,926
|
$2,799
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-38
|
$4,555,705
|
$91,114
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UV/Vit D in radiologic technologists
|
ZIA CP010133-10416
|
$173,051
|
$34,610
|
Freedman, Daryl
|
DCEG (NCI)
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-23
|
$2,179,856
|
$87,194
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Uses of GEM models for Translational Cancer Research
|
5U01CA141508-03
|
$817,169
|
$408,585
|
CHIN, LYNDA
|
DANA-FARBER CANCER INSTITUTE
|
|
Use of aAPC for Melanoma Adoptive Immunotherapy
|
2R01CA108835-06A2
|
$318,780
|
$318,780
|
SCHNECK, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
2P30CA014089-36
|
$6,160,984
|
$61,610
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S1
|
$50,000
|
$500
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S2
|
$244,500
|
$2,445
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S3
|
$74,923
|
$749
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-27
|
$1,400,911
|
$14,009
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S2
|
$50,000
|
$500
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S3
|
$5,694,947
|
$56,949
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
2P30CA134274-04
|
$1,565,163
|
$109,561
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Tumor-Reactive Immune Cells Generated from Drosphila Antigen Presenting Cells
|
ZIA BC 011228
|
$92,929
|
$92,929
|
Yang, James
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$195,669
|
$9,783
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens
|
ZIA BC 010954
|
$533,041
|
$106,608
|
Hurwitz, Arthur
|
CCR (NCI)
|
|
Tumor gene expression in vitro and in vivo
|
ZIA BC 008905
|
$456,341
|
$136,902
|
Lowy, Douglas
|
CCR (NCI)
|
|
Tumor Banking for the Southwest Oncology Group
|
3U24CA114748-05S2
|
$124,541
|
$12,454
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Treatment of Melanoma with Optimzed Peptide Vaccines
|
5R01CA136828-03
|
$336,129
|
$336,129
|
Celis, Esteban
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Translational Research in Cancer
|
3P30CA056036-12S1
|
$75,000
|
$1,500
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-12
|
$2,947,311
|
$58,946
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Transduction of T cells to improve migration to tumor
|
5R01CA116206-07
|
$500,533
|
$500,533
|
HWU, PATRICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Training Program in Cancer Biology
|
5T32CA078207-13
|
$632,546
|
$208,740
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE
|
|
Tpl2 in Carcinogenesis-Related Inflammation
|
1UA5CA152907-01A1
|
$380,871
|
$380,871
|
DeCicco-Skinner, Kathleen
|
AMERICAN UNIVERSITY
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-28
|
$797,203
|
$7,972
|
MOWAT, REX
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
To Understand/Augment OX40-mediated Tumor Immunotherapy
|
5R01CA102577-08
|
$306,263
|
$153,132
|
WEINBERG, ANDREW
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$528,614
|
$79,292
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Therapeutic Potential of IL-15 Plasmid Delivery to Tumors Using Electroporation
|
5R01CA122518-04
|
$101,681
|
$101,681
|
HELLER, RICHARD
|
OLD DOMINION UNIVERSITY
|
|
Therapeutic approaches that target cancer cell metabolism
|
5K23CA120862-04
|
$137,295
|
$96,107
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma
|
3P50CA093459-07S1
|
$87,090
|
$87,090
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma
|
5P50CA093459-07
|
$2,185,000
|
$2,185,000
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Unfolded Protein Response in Melanoma Progression and Chemoresistance
|
5R01CA125017-05
|
$27,667
|
$27,667
|
SOENGAS, MARIA
|
SPANISH NATIONAL CANCER CENTER
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
5P50CA086306-12
|
$1,487,860
|
$267,815
|
Herschman, Harvey
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
Total relevant funding to Melanoma for this search: $115,640,464
|